Uncategorized
Endospan Enters Into Strategic Distribution Agreement With CryoLife
HERZLIYA, Israel--(BUSINESS WIRE)--Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease, today announced it has entered into strategic distribution and credit facility agreements with CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease. Under the terms of the agreement, CryoLife will have exclusive European distribution rights to NEXUS™, the first off-the-shelf endovascular stent graft system approved for the repair of